The OJC 54: Cancer Care in the Wake of a Cyber Attack
The Oncology Journal Club Episode 54: Cancer Care in the Wake of a Cyber Attack…
Browsing: tyrosine kinase inhibitor
ESMO 2021: Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumour
The first randomised study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs…
Potential drug treatment for particular type of lung-cancer
The effectiveness of cancer treatment is often hampered by cancer cells being heterogeneous. This is…
Early prediction of resistance to tyrosine kinase inhibitors in NSCLC
A study published in the journal Oncotarget has reported that at clinical progression, 64 EGFR T790M plasma positive…
ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…